Event and Peri-procedural Replacement Therapy in Patients with Hemophilia.

Slides:



Advertisements
Similar presentations
M.P. Muldoon, M. D. Orthopedic Medical Group of San Diego.
Advertisements

Steroid Joint injections
CONSERVATIVE CARE Douglas Koontz, M.D. Neurosurgery Specialists.
Dental Care at Paradise Animal Hospital. How can I tell if my pet has dental disease? The common signs of dental disease are redness of the gums, bad.
Question: How should we manage periprocedural anticoagulation? Paper: Management of Antithrombotic Therapy in Patients Undergoing Invasive Procedures Todd.
Pain Management Coding
The Basics of Hemophilia Nursing Working Group National Hemophilia Foundation.
Botulinum toxin type A for the prevention of headaches in adults with chronic migraine.
Hemophilia What is Hemophilia? Hemophilia is an inherited bleeding disorder in which there is a deficiency or lack of factor VIII or factor IX clotting.
Copyright © 2004 by Delmar Learning, a division of Thomson Learning, Inc. ALL RIGHTS RESERVED. 1 Chapter 16 Management of Pain and Anxiety.
By: Bekim Ameti. Information On Hemophilia Hemophilia is the oldest known heredity bleeding disorder. Hemophilia has been known for thousands of years.
CHEST-2012: High Points and Pearls Alan Brush, MD, FACP Chief, Anticoagulation Management Service Harvard Vanguard Medical Associates.
Oral and Maxillofacial Surgery Consulting Specialist.
Hemophilia A By Marissa Miuccio.
Pharmacology Chapter 15.
Funding: Health Foundation, ESVS GA versus LA The Story So Far Dr Andrew R Bodenham The General Infirmary at Leeds.
By: Brandon Jamison, Tucker Dodson, Nami Small.  There are several conditions can cause elbow pain and disability, and lead patients and their doctors.
Factor Inhibitors: Cases Lisa N Boggio, MS, MD Rush University Medical Center.
Peri-operative management of anticoagulation Marc Carrier MD, MSc FRCPC Assistant Professor, University of Ottawa Associate Scientist, Ottawa Health Research.
PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM
©2013 Delmar, Cengage Learning. All Rights Reserved. May not be scanned, copied, duplicated, or posted to a publicly accessible website, in whole or in.
Ben, Trina, Jake, Levi. OBJECTIVES History Characteristics Methods of Cryotherapy Evidence Based Research Review Questions References.
Chiropractic Dr. Christopher Good, DC, MA(Ed), CCSP
Joint Special Operations Medical Training Center LOCAL/REGIONAL ANESTHESIA SFC Shrader.
TREATMENT OF ENDOCRINE EMERGENCIES Sakharova Inna. Ye., M.D, Ph.D.
Hemophilia U & I Inc., USA Payor Education Presentation Last Updated; January, 2012.
The Role of Thromboprophylaxis in Elective Spinal Surgery The Role of Thromboprophylaxis in Elective Spinal Surgery VA Elwell, N Koo Ng, D Horner & D Peterson.
LOCAL ANESTHETICS AND REGIONAL ANESTHESIA. Local Anesthetics- History cocaine isolated from erythroxylum coca Koller uses cocaine for topical.
HICKMAN CATHETER Thrombotic complications associated with venous access devic Thrombotic complications associated with venous access devices Occlusion.
PRINCIPLES OF PROPHYLAXIS OF INFECTION 1)Procedure should have significant risk of infection 2)Choose correct antibiotic 3)Antibiotic plasma level must.
The Hemophilia Federation of America (HFA) is a national nonprofit organization that assists and advocates for the bleeding disorders community. MISSION.
© 2014 Direct One Communications, Inc. All rights reserved. 1 Expanding Therapeutic Options for Hemophilia A and B: Results of Recent Clinical Trials Holleh.
Implanted Ports: Procedure for Access and Care
ANTI-COAGULATION. ENOXAPARIN DOSING Obesity (BMI >= 40 kg/m2) – may increase prophylactic dose by 30% such as in bariatric surgery Abdominal Surgery ….
Biomaterials. Orthopedic Materials Bioceramic Orthopedic Implants.
CRYOTHERAPY Ben, Trina, Jake, Levi.
4 year old boy comes in with painful, swollen R ankle after having fallen off of a swing 6 hours previously, landing on his knee. No history of bruising;
Hemorrhagic diatheses in children. Gastrointestinal bleedings. Sakharova I. Ye., MD, PhD.
Anesthesia and Sedation
Peri-Operative anticoagulation /antiplatelet therapy A Shift in Paradigm BMHGT04/29/09.
Drugs Susan Louw Haematology Registrar. 4 Questions to ask: Can I stop? (What is the risk of thrombosis?) Should I stop? (What is the risk of bleeding?)
ANTI-COAGULATION. ENOXAPARIN DOSING Obesity (BMI >= 40 kg/m2) – may increase prophylactic dose by 30% such as in bariatric surgery Abdominal Surgery ….
Hemophilia Management: Joint Bleeds and Prophylaxis.
Rare Bleeding Disorders Factor XI deficiency FX deficiency Fibrinogen deficiency Dr Niamh O’Connell The National Centre for Hereditary Coagulation Disorders,
G UIDELINES FOR THE P ERI -P ROCEDURAL M ANAGEMENT OF A DULTS T AKING T ARGET S PECIFIC A NTICOAGULANTS (TSOAC S ): DABIGATRAN, RIVAROXABAN, APIXABAN,
Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism ‘ The PADIS-PE Trial’ Nate Peyton.
Warfarin Therapy Aaqid Akram MBChB (2013) Clinical Education Fellow.
<Disease review>
Date of download: 6/22/2016 From: Prolonged Versus Standard-Duration Venous Thromboprophylaxis in Major Orthopedic Surgery: A Systematic Review Ann Intern.
Lesson XIII: Anesthesia
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 41 Musculoskeletal Care Modalities.
Introduction - Perioperative management of patients on warfarin or antiplatelet therapy involves assessing and balancing individual risks for thromboembolism.
Low Procedural Bleed Risk
Regional anesthesia on anticoagulants
Hemophilia 2009.
Bisphosphonate treatment: An orthodontic concern calling for a proactive approach  James J. Zahrowski  American Journal of Orthodontics and Dentofacial.
Supracscapular Nerve Block for Shoulder Pain
Trigger Point Injections of the Back
NATURE AND SCOPE OF THE HEMOPHILIA NURSE John C
Supplemental injection techniques
Ilioinguinal / Iliohypogastric Block
Hemophilia.
HICKMAN CATHETER. HICKMAN CATHETER Thrombotic complications associated with venous access devices Occlusion of lumen Fibrin sheath formation Venous.
Individualizing Prophylaxis in Hemophilia
What Does It Take to Be a Long-Acting Replacement Therapy in Hemophilia A?
Initial Office Evaluation
Periprocedural Management of Patients with Bleeding Disorders
Selecting Treatment Approaches in Hemophilia
Thrombophilia in pregnancy: Whom to screen, when to treat
FY 2019 ICD-10-PCS Guideline Changes
Presentation transcript:

Event and Peri-procedural Replacement Therapy in Patients with Hemophilia

LIMITED DATA: OBSERVATIONAL BASED THERAPY

EVENT BLEEDS

Joint Bleeding Management Episodic Therapy – Single dose u/kg (target 40-50%) May need higher dose 40 u/kg if delay treatment >3 hrs – RCT using Kogenate as prophylaxis vs. episodic Rx Prophylaxis 25 IU/kg every other day Episodic – 40 IU/kg at onset of bleed – 20 IU/kg at 24 and 72 hours – 20 IU/kg then encouraged every other day until pain and mobility impairment completely resolved (up to 4 weeks) – Ice – Joint aspiration? If septic joint considered

Epistaxis Most bleeds need local measures only If prolonged (>20 minutes) or major (gushing) – Single dose u/kg (target 40-50%) – Amicar x 5-10 days Load with 5 grams, then 2.5 grams every 6 hours – NeoSynepherine

Muscle Bleeds Large muscle bleed – Initial dose u/kg (target %) – Maintenance doses u/kg every 12 hours for total 2-4 days – Based on symptoms – Ice and limit activity Small muscle sans neurovascular compromise – Initial dose u/kg (target 40-50%) – Maintenance doses u/kg every 12 hours for total 1-2 days – Based on symptoms – Ice and limit activity

Neck Soft Tissue or Tonsillar Bleeds Large muscle bleed – Initial dose u/kg (target %) – Maintenance doses 25 u/kg every 12 hours for total 3-5 days after bleeding has stopped – Amicar x 5-10 days Load with 5 grams, then 2.5 grams every 6 hours – Maintain and protect airway

Intracranial Bleeds Intracranial bleeds – Initial dose u/kg (target %) – Maintenance doses u/kg every 12 hours for 14 days (until resolved) – Prophylaxis therafter

PROCEDURAL PLANNING

Vaccinations Nothing needed if either: – Using 25 gauge needle – Subcutaneous injection If using larger needle used for IM injection – u/kg x 1 dose – Ice

Dental Procedures Single extraction – Initial dose 25 u/kg (target 50%) – Amicar x 5 days Load with 5 grams, then 2.5 grams every 6 hours Multiple extractions – Initial dose u/kg (target %) – Maintenance doses u/kg every 12 hours for total 3 days – Amicar x 7-10 days Load with 5 grams, then 2.5 grams every 6 hours

Dental Procedures Root canal – Nothing needed specifically – But, the anesthesia is nerve root block Initial dose 25 u/kg (target 50%) Amicar x 5 days – Load with 5 grams, then 2.5 grams every 6 hours

Port or Central Venous Access Device Placement Intravenous Device Placement – Initial dose u/kg (target %) – Maintenance doses 25 u/kg every 12 hours for total 3 days

Endoscopy/Colonoscopy No biopsy needed – Initial dose u/kg (target %) – Amicar x 5 days Load with 5 grams, then 2.5 grams every 6 hours If biopsy performed – Initial dose u/kg (target %) – Maintenance doses 25 u/kg x one dose 8-12 hours after the first dose then 25 u/kg every 12 hours for 2-4 additional days (total 3-5 days of Rx) – Amicar x 5-7 days Load with 5 grams, then 2.5 grams every 6 hours Advise to clip rather than cauterize if biopsy needed during the procedure

General Surgery – Initial dose u/kg (target %) – Maintenance doses 25 u/kg x one dose 6-8 hours after the first dose then 25 u/kg every 12 hours for a total 7-10 days of Rx

Orthopedic — Minor Minor Orthopedic Surgery – Initial dose u/kg (target %) – Maintenance doses 25 u/kg x one dose 6-8 hours after the first dose then 25 u/kg every 12 hours for a total 5-7 days of Rx

Orthopedic – Major Major Orthopedic Surgery – Initial dose u/kg (target %) – Maintenance doses 25 u/kg x one dose 6-8 hours after the first dose then 25 u/kg every 12 hours for a total 14 days of Rx 25 units every 24 hours prn prior to physical therapy for additional 2-4 weeks as directed by duration of PT – DVT prophylaxis?